← Back to catalogue

Architect

FDA UDI

Class II (US FDA UDI)

by Abbott Laboratories, Inc.

Identity

Trade Name
ARCHITECT FDA UDI
Generic Name
Total creatine kinase (CK) IVD, reagent FDA UDI
Device Name
Creatine Kinase FDA UDI
Model / Reference
7D63-21 FDA UDI
Description
Creatine Kinase FDA UDI

Identifiers

Catalog Number
07D6321 FDA UDI
Primary DI / UDI-DI
00380740012878 FDA UDI
FDA Product Code
CGS FDA UDI
GMDN Term
Total creatine kinase (CK) IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1215 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Total creatine kinase (CK) IVD, reagent

Architect by Abbott Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Total creatine kinase (CK) IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI aa02f054-a102-45e1-a0fe-1577cfdf4672 36 fields · synced Jun 1, 2026